No Benefit Seen From Most Workplace Wellness Programs
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
MONDAY, Jan. 15, 2024 -- Employees at many companies are urged to take advantage of free wellness programs focused on mindfulness, life coaching, better sleep and many other issues.
Too bad most won't actually boost their well-being, a new study of over 46,000 British workers finds.
Only one of the 90 different workplace wellness offerings appeared to boost well-being: Getting employees involved in charity work or volunteering, the researchers found.
The findings "pose a challenge to the popularity and legitimacy of individual-level mental well-being interventions like mindfulness, resilience and stress management, relaxation classes and well-being apps," concludes the study's sole author, William Fleming. He's a fellow at Oxford University’s Wellbeing Research Center.
Fleming's research is based on data from the Britain’s Healthiest Workplace surveys for 2017 and 2018, representing workers at 233 different organizations.
He compared the survey answers of "matched pairs" of people who were working at the same company: One who was using a wellness program, and another who was not.
Because it is a survey, the data only focuses on worker well-being at a specific moment in time, not before and after the introduction of workplace wellness programs.
The main finding: With the exception of charity/volunteer programs, workers' mental well-being didn't seem to change regardless of whether or not they were involved in any of the many programs on offer.
Speaking with the New York Times, Fleming said he knew the findings would be "controversial." He believes that if companies truly want workers to feel better, improving working conditions (factors such as schedules, pay and performance reviews) may be the best way to go.
“If employees do want access to mindfulness apps and sleep programs and well-being apps, there is not anything wrong with that,” he told the Times. “But if you’re seriously trying to drive employees' well-being, then it has to be about working practices.”
However, others took issue with his research.
Adam Chekroud is an assistant professor of psychology at Yale University and co-founder of Spring Health, a platform that links employees with psychotherapy and online help with medications, to help boost mental health.
One 2022 study of Spring Health, involving 1,132 U.S. workers who used the service, found that most did see an easing of their depression. Days absent from work also lessened, and self-reports of workplace productivity rose.
Speaking to the Times, he said Fleming's study focused on interventions that were "not highly credible," so that it dismissed workplace wellness interventions overall.
“There is recent and highly credible data that things like mental health programs do improve all those metrics that he mentions,” Chekroud said.
But another expert, Dr. David Crepaz-Keay, supported Fleming's findings.
The study is "certainly more robust" than "most of the research that has created the consensus that employee assistance works," Crepaz-Keay told the Times. He's head of research and applied learning at the Mental Health Foundation in the United Kingdom, and has has advised the World Health Organization and Public Health England on initiatives aimed at boosting mental health.
Fleming's study was published Jan. 10 in the Industrial Relations Journal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-16 04:15
Read more
- ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
- Patients Living Outside Metropolitan Statistical Areas Travel Farther for Health Care Visits
- Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- One in Six Emergency Departments Have High Pediatric Readiness
- AI Might Help Pick Up Heart Trouble in Dogs
- Cognitive Decline Slowed With Cognitive Remediation in At-Risk Adults
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions